What does CUSIP 75629V104 represent in this 13F holders report?

CUSIP 75629V104 is the security identifier for RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock in Q2 2023?

155 institutional investors reported RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX)

CUSIP: 75629V104

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / Common Stock
Total 13F shares: 127,547,789
Total 13F value: $952,749,699
Share change: +1,393,964
Put/Call ratio: 96%
SEC-reported price per share: $7.47
Number of holders: 155
Value change: +$12,757,431
Number of buys: 81
Number of sells: 69
Shares outstanding: 525,448,476

Security key

75629V104

Report period

Q2 2023

Institutions

155

Top holders

RXRX full security history Ownership snapshot Full 13F holder table RECURSION PHARMACEUTICALS, INC. SEC filings RECURSION PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VIKING GLOBAL INVESTORS LP

Disclosed value leader

VIKING GLOBAL INVESTORS LP

Comparable rows

15/15

Latest evidence

31 Mar 2023

13F Lead comparable stake: 28% Showing 1-6 of 15 holder rows.

Quick read

VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 28%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VIKING GLOBAL INVESTORS LP's linked filing trail.

Comparable ownership Top 5

VIKING GLOBAL INVESTORS LP 28%

Anchorage Capital Group, L.L.C. 13%

GENERAL ATLANTIC, L.P. 6.2%

SB INVESTMENT ADVISERS (UK) LTD 4.7%

MIC Capital Management UK LLP 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VIKING GLOBAL INVESTORS LP	13F Company 13F	28%	$190,303,218 143,085,126 shares	—	31 Mar 2023
Anchorage Capital Group, L.L.C.	13F Company 13F	13%	$92,906,609 69,854,593 shares	—	31 Mar 2023
GENERAL ATLANTIC, L.P.	13F Company 13F	6.2%	$42,985,462 32,319,896 shares	—	31 Mar 2023
SB INVESTMENT ADVISERS (UK) LTD	13F Company 13F	4.7%	$32,490,824 24,429,191 shares	—	31 Mar 2023
MIC Capital Management UK LLP	13F Company 13F	1.6%	$56,373,229 8,451,758 shares	—	31 Mar 2023
Kinnevik AB (publ)	13F Company 13F	1.5%	$51,045,917 7,653,061 shares	—	31 Mar 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

155

127,547,789

Rows available

155

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

157

Q2 2023 holders

155

Holder diff

-2

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q2 2023 value	Value change	Value Chg %